Broader Scope Needed for Unitaid AIDs Drug Patent Pool, Cipla Urges
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Just three weeks after Unitaid decided to move forward with a long-debated plan to establish patent pools for AIDS medicines, the owner of renowned Indian generics maker Cipla says the project needs a much wider scope and a lot more clarity if it is to have any effect